COACTIN Drug Patent Profile
✉ Email this page to a colleague
When do Coactin patents expire, and when can generic versions of Coactin launch?
Coactin is a drug marketed by Roche and is included in one NDA.
The generic ingredient in COACTIN is amdinocillin. There are three drug master file entries for this compound. Additional details are available on the amdinocillin profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for COACTIN?
- What are the global sales for COACTIN?
- What is Average Wholesale Price for COACTIN?
Summary for COACTIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 58 |
| Patent Applications: | 3,414 |
| DailyMed Link: | COACTIN at DailyMed |
US Patents and Regulatory Information for COACTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | COACTIN | amdinocillin | INJECTABLE;INJECTION | 050565-003 | Dec 21, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Roche | COACTIN | amdinocillin | INJECTABLE;INJECTION | 050565-001 | Dec 21, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Roche | COACTIN | amdinocillin | INJECTABLE;INJECTION | 050565-002 | Dec 21, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
